{"name":"Nammi Therapeutics Inc","slug":"nammi-therapeutics-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2025-02-17","type":"pipeline","source":"GlobeNewswire","summary":"Metastatic Castration-Resistant Prostate Cancer Market to - GlobeNewswire","headline":"Metastatic Castration-Resistant Prostate Cancer Market to","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAJBVV95cUxNcHNEWHo5ZG9BQVlfaXFVYjlZaW1lcnE0TmFSTTJlczB6QjhDUTFVR2YxNDN2UGFTNEt3QmRvMUZiNkxWREJqY1RsZ2dxd0hyZkx0Z3EtMVJPYVJHN0N6QWl4SzJWWHhEblZBYXRYVFd1TU5VNTBhWUlhWWRZU1ppYjNXYkZoNWR6RUt1Zml5MV9XTDRYZGdfTC1BeXh5dk8xVnllbGViamxOdDZZNWl5d0VVYklRaVBXcU5yMmlyVDJLdFQ1TjBHQWtfZlpad0U3djVBYWZsNWxTWmxwSWNwVEdSNFVZUkdUWERFa1JnTTJ1OHh5RXY4LTZ0VWdnbS1BQkVhckMxWW0wbTMwY0lRa3JhUk5HcC1qRlZkbjJ0bzI?oc=5","date":"2024-11-08","type":"trial","source":"PR Newswire","summary":"Nammi Therapeutics, Inc. Announces First Patient Dosed with QXL138AM in a Phase 1 Study Evaluating Advanced Solid Tumors and Multiple Myeloma - PR Newswire","headline":"Nammi Therapeutics, Inc. Announces First Patient Dosed with QXL138AM in a Phase 1 Study Evaluating Advanced Solid Tumors","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwJBVV95cUxNYWZIR1FURDU4dFFXaEs3bjFkYk4zOERRa25WempmaDRMcndkNEtQTV81NTlUWWdONjNxLVdrNmlfMHBRZVU1a055NlhFLTVQcEs0LTNFWktRZDR1RHVtVjRIMzBuMVZuUFhDa01WT3lKaTY4ckZQRjFlSnc2YzNjTjhRbU5yYjN3NC1pSU1ZYTM3b1pVRjhyVVRxMGxRbFpmcUtoQ0VDTlY3VTJySExPM0t3a1JhU3pWUGROWV9yTmNHLXZ4UUZybzdDYS05R3lwRFozaGJHTkNFVjRTV0dfb2U5VDNEODhBaDdNTmJNNl9FUzJKT29ZV016Ynk0VTZjdjQ2S3NDV3paeVpWNDFUN2IzaFpKd0RZc21mSlZwTXhxeUVnNTRuQ0hQQ0pGamZTT1M5ZjNXZ1lGdU0zbzcteXdUWQ?oc=5","date":"2024-10-15","type":"trial","source":"GlobeNewswire","summary":"Prostate Cancer Clinical Trial Pipeline Experiences - GlobeNewswire","headline":"Prostate Cancer Clinical Trial Pipeline Experiences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswJBVV95cUxOMzgtSUdCamR1Tzk0R2tjWTducFAtaDRIT2lYQ0tleUtFczFZeXBhc3lVMEFIUlMtU3ZSRUhQZHNuSmpibVNmZzIyaVk0RGJ6cjBXSUV0Wi1uUWVzanNBbnR4VmpxcjBIc3pKd0Y2VC0yVzN6eXZYNUpkZHNZNEtoaFdsUVNtdWV4SkhiUDVlMlk4WHg2YnFQTkRRd1p2NWlEUUZXTmxxOXF6Nkdlc0tBekFKdEdMS29ZVVNDZERVVVZNdHltMUlPZmdSXy1fT2pCQXQzcnRIV2RGUnVsQVRSN1REVUhRZzVJNlduRFV5azlxd1VHSnNZbi1JOVJza081angtWmNIMXdRTE9BZnJqZ2JUNURvQmF5OFY4M0l2UENuT1hjZXRES2NXZHVVcktWeEow?oc=5","date":"2024-08-06","type":"pipeline","source":"PR Newswire","summary":"Nammi Therapeutics, Inc. Completes Series B Round with Investment from MMRF's Myeloma Investment Fund; Advances Clinical Development of Lead Program, QXL138AM - PR Newswire","headline":"Nammi Therapeutics, Inc. Completes Series B Round with Investment from MMRF's Myeloma Investment Fund; Advances Clinical","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNS0FqRDlJU0p1ZDM3V2tlS3o3Y19aTEZabHAtWkxQYXhEZTZzWHYyU2RQMVBGNTZNS01EaVgzSTBZU09pRTZpWlNZVlhqRHhpOHBFbHpodDl0SGdSejhMTkoyV1gxQUpYdWJXZEJRZm9VUUZwMDlRc2J6S0Zuc05qOGRxbGJLTnNIcEw1OFpGdnVaUGV3aFJvajZSYllNU19UWHVqellMMFJLMG1DTkN3OHVUY2xLeWUyRmRvUERBeGNFU0tuWkV1eThjQQ?oc=5","date":"2023-03-13","type":"pipeline","source":"Los Angeles Business Journal","summary":"Local Companies and Research Institutes at Forefront of Cancer Immunotherapy Development - Los Angeles Business Journal","headline":"Local Companies and Research Institutes at Forefront of Cancer Immunotherapy Development","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiyAFBVV95cUxNUkVBNHR0OHhYVzZJSUpnNWJyYlBDVHFNU0QzUUVvbThjZVNBZmQwaFljZHNZY3k3alN3V1FKZGRxLWFPQzUyU0xhRzEybDg5ZFlMWWdDR2g0eUl4LUJPYkFzWE1wMVlhVlBHWFFlc2ZvdnpMcUpFUGY0Y1d1ZUxXVDBNU0FkaWtfZVVMdGQ2NEV1azRpbGdKVkVQZ293UWdMbWJOY2REWW1YUmJQSnlJaGkzNlV1ekhsNElObEpuVnBHQ29MeXVaYw?oc=5","date":"2022-09-08","type":"trial","source":"michiganmedicine.org","summary":"Study suggests commonly used prostate cancer treatment rewires engine of prostate tumors - michiganmedicine.org","headline":"Study suggests commonly used prostate cancer treatment rewires engine of prostate tumors","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}